Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorAssaf-Harofeh Medical Center

About this trial

Analgesia is one of the pillars of anesthesia. One of the common opiates for pain relief, with a short half-life, is Remifentanil. However, following Remifentanil treatment an increased sensitivity to pain \[hyperalgesia\] appears. The aim of the study is to compare the effects between complementary treatments, like Ketalar and Dexmedetomidine, in preventing increased sensitivity to pain after Remifentanil treatment

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients with sensitivity to the anesthetic

Patients with chronic pain who are in regular treatment

Urgent surgery

Patients with ischemic heart disease

Trial design

Treatments tested in this trial

  • Ketalar
  • Dexmedetomidine

Treatment groups

90 Participants
are divided into 2 treatment groups

Sponsors and collaborators